HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Need for a trial of solanezumab in mild Alzheimer's disease.

AuthorsDavid Torgerson
JournalBMJ (Clinical research ed.) (BMJ) Vol. 351 Pg. h4441 (Sep 01 2015) ISSN: 1756-1833 [Electronic] England
PMID26330409 (Publication Type: Letter, Comment)
Chemical References
  • Antibodies, Monoclonal, Humanized
Topics
  • Alzheimer Disease (drug therapy)
  • Antibodies, Monoclonal, Humanized (pharmacology)
  • Humans
  • Mass Media

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: